Cargando…

Sustained Diet-Induced Remission in Pediatric Crohn’s Disease Is Associated With Kynurenine and Serotonin Pathways

BACKGROUND: Both the Crohn’s disease exclusion diet combined with partial enteral nutrition (CDED+PEN) and exclusive enteral nutrition (EEN) can induce remission in mild-to-moderate pediatric Crohn’s disease and are associated with a marked decrease in fecal kynurenine levels. This suggests a link b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghiboub, Mohammed, Boneh, Rotem Sigall, Sovran, Bruno, Wine, Eytan, Lefèvre, Antoine, Emond, Patrick, Verburgt, Charlotte M, Benninga, Marc A, de Jonge, Wouter J, Van Limbergen, Johan E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Leading Off
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152286/ https://www.ncbi.nlm.nih.gov/pubmed/36637175 http://dx.doi.org/10.1093/ibd/izac262

Ejemplares similares

Ultra-high Magnification Endocytoscopy and Molecular Markers for Defining Endoscopic and Histologic Remission in Ulcerative Colitis—An Exploratory Study to Define Deep Remission
por: Iacucci, Marietta, et al.
Publicado: (2021)

The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn’s & Colitis Foundation
por: Park, K T, et al.
Publicado: (2020)

Bacterial Mucosa-associated Microbiome in Inflamed and Proximal Noninflamed Ileum of Patients With Crohn’s Disease
por: Olaisen, Maya, et al.
Publicado: (2020)

Increased Colonic Epithelial Permeability and Mucosal Eosinophilia in Ulcerative Colitis in Remission Compared With Irritable Bowel Syndrome and Health
por: Katinios, Georgios, et al.
Publicado: (2020)

Prediction of Crohn’s Disease Stricturing Phenotype Using a NOD2-derived Genomic Biomarker
por: Ashton, James J, et al.
Publicado: (2022)

Natural History and Risk Stratification of Recurrent Crohn’s Disease After Ileocolonic Resection: A Multicenter Retrospective Cohort Study
por: Joustra, Vincent, et al.
Publicado: (2021)

The Emerging Role of Noncoding RNAs in Pediatric Inflammatory Bowel Disease
por: Jabandziev, Petr, et al.
Publicado: (2020)

Interrogating the Gut-Brain Axis in the Context of Inflammatory Bowel Disease: A Translational Approach
por: Collins, Stephen M
Publicado: (2020)

Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD
por: Burgueño, Juan F, et al.
Publicado: (2020)

Multidimensional Impact of Mediterranean Diet on IBD Patients
por: Chicco, Fabio, et al.
Publicado: (2020)

Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity
por: Fang, Xin, et al.
Publicado: (2020)

Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease
por: Verstockt, Sare, et al.
Publicado: (2021)

Development of a Personalized Intestinal Fibrosis Model Using Human Intestinal Organoids Derived From Induced Pluripotent Stem Cells
por: Estrada, Hannah Q, et al.
Publicado: (2021)

Development and Validation of an Inflammatory Bowel Disease Severity Index Using US Administrative Claims Data: A Retrospective Cohort Study
por: Chen, Grace, et al.
Publicado: (2020)

Multiple Switches From the Originator Infliximab to Biosimilars Is Effective and Safe in Inflammatory Bowel Disease: A Prospective Multicenter Cohort Study
por: Hanzel, Jurij, et al.
Publicado: (2021)

Genetic Profiling of Colorectal Carcinomas of Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
por: de Krijger, Manon, et al.
Publicado: (2022)

Lower Impact of Disease on Daily Life and Less Fatigue in Patients With Inflammatory Bowel Disease Following a Lifestyle Intervention
por: Lamers, Carlijn R, et al.
Publicado: (2022)

Transcriptional Behavior of Regulatory T Cells Predicts IBD Patient Responses to Vedolizumab Therapy
por: Abreu, Maria T, et al.
Publicado: (2022)

Molecular and Functional Characterization of Human Intestinal Organoids and Monolayers for Modeling Epithelial Barrier
por: Jelinsky, Scott A, et al.
Publicado: (2022)

The Risk of Serious Infections Before and After Anti-TNF Therapy in Inflammatory Bowel Disease: A Retrospective Cohort Study
por: Holmgren, Johanna, et al.
Publicado: (2022)

Label-Free Characterization and Quantification of Mucosal Inflammation in Common Murine Colitis Models With Multiphoton Imaging
por: Kreiss, Lucas, et al.
Publicado: (2022)

Health Care Disparities, Social Determinants of Health, and Emotional Impacts in Patients with Ulcerative Colitis: Results from a Global Ulcerative Colitis Narrative Patient Survey
por: Odufalu, Florence-Damilola, et al.
Publicado: (2023)

Creation of an Inflammatory Bowel Disease Referral Pathway for Identifying Patients Who Would Benefit From Inflammatory Bowel Disease Specialist Consultation
por: Scott, Frank I, et al.
Publicado: (2022)

Successful Dietary Therapy in Paediatric Crohn’s Disease is Associated with Shifts in Bacterial Dysbiosis and Inflammatory Metabotype Towards Healthy Controls
por: Verburgt, Charlotte M, et al.
Publicado: (2022)

Nutritional Therapy Strategies in Pediatric Crohn’s Disease
por: Verburgt, Charlotte M., et al.
Publicado: (2021)

Nutritional Therapy to Modulate Tryptophan Metabolism and Aryl Hydrocarbon-Receptor Signaling Activation in Human Diseases
por: Ghiboub, Mohammed, et al.
Publicado: (2020)

Gait Speed and Confidence Levels in Persons Using 1 and 2 Canes While Walking a 4-m Course
por: Lisenby, Marion A.
Publicado: (2017)

Collaborative research in surgery: a rising tide lifts all boats
por: Li, Elizabeth, et al.
Publicado: (2022)

Collaborative research: population-based data and validation are necessary
por: Björck, Martin
Publicado: (2022)

Shared decision-making should be a standard part of surgical care
por: Ubbink, Dirk T
Publicado: (2022)

Personalised azithromycin+metronidazole (PAZAZ), in combination with standard induction therapy, to achieve a faecal microbiome community structure and metagenome changes associated with sustained remission in paediatric Crohn’s disease (CD): protocol of a pilot study
por: Verburgt, Charlotte M, et al.
Publicado: (2023)

The relationship between the commensal microbiota levels and Crohn's disease activity
por: de Alencar Junior, Hagamenon, et al.
Publicado: (2020)

Nutritional Therapies and Their Influence on the Intestinal Microbiome in Pediatric Inflammatory Bowel Disease
por: Hart, Lara, et al.
Publicado: (2021)

Targeting the Serotonin 5-HT(7) Receptor in the Search for Treatments for CNS Disorders: Rationale and Progress to Date
por: Nikiforuk, Agnieszka
Publicado: (2015)

Childhood antibiotics as a risk factor for Crohn's disease: The ENIGMA International Cohort Study
por: Mak, Joyce W Y, et al.
Publicado: (2022)

The many faces of mitophagy
por: Ivatt, Rachael M, et al.
Publicado: (2014)

IBD BioResource: an open-access platform of 25 000 patients to accelerate research in Crohn’s and Colitis
por: Parkes, Miles
Publicado: (2019)

Anti-Tumour Necrosis Factor Therapy for Paediatric Crohn’s Disease: Improved Benefits Through Treatment Optimisation, Deeper Understanding of Its Risks, and Reduced Costs due to Biosimilar Availability
por: Cozijnsen, M. A., et al.
Publicado: (2017)

Systematic reporting of computed tomography enterography/enteroclysis as an aid to reduce diagnostic dilemma when differentiating between intestinal tuberculosis and Crohn's disease: A prospective study at a tertiary care hospital
por: Israrahmed, Amrin, et al.
Publicado: (2020)

Off‐label prescriptions of drugs used for the treatment of Crohn’s disease or ulcerative colitis
por: Simsek, Melek, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1j42fnoo0t509hm238b4k5fqrl